Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 10.14 is 59% below its 5-year average of 24.85, near the low end of its 5-year range (10.14–115.95).
As of the fiscal period ended Tuesday, June 30, 2026. 26.28% below its 12-month average of 13.76.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.14.
CURRENT RATIO
10.14
CURRENT RATIO AVG TTM
13.76
CURRENT RATIO AVG 3Y
17.04
CURRENT RATIO AVG 5Y
24.85
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-26.28%
CURRENT VS 3Y AVG
-40.47%
CURRENT VS 5Y AVG
-59.18%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+170.48%
vs the sector median at left
Nautilus Biotechnolgy, Inc.
Market Cap
$227.79M
Current Ratio
10.14
TTM Avg
13.76
3Y Avg
17.04
5Y Avg
24.85
Market Cap
$234.18M
Current Ratio
21.72
TTM Avg
10.47
3Y Avg
8.50
5Y Avg
9.09
Market Cap
$235.43M
Current Ratio
48.62
TTM Avg
31.63
3Y Avg
25.23
5Y Avg
22.81
Market Cap
$219.48M
Current Ratio
6.45
TTM Avg
11.52
3Y Avg
11.11
5Y Avg
13.89
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nautilus Biotechnolgy, Inc. (NAUT) | $227.79M | 10.14 | 13.76 | 17.04 | 24.85 |
| Biodesix, Inc. (BDSX)vs › | $227.77M | 2.85 | 2.31 | 2.04 | 2.06 |
| MacroGenics, Inc. (MGNX)vs › | $230.22M | 2.96 | 4.51 | 4.52 | 4.67 |
| Vogenx Inc. (VOGX)vs › | $224.23M | N/A | N/A | N/A | N/A |
| BioAge Labs Inc. (BIOA)vs › | $231.49M | 17.19 | 13.55 | 8.08 | 8.08 |
| InflaRx N.V. (IFRX)vs › | $231.99M | 8.22 | 4.59 | 5.79 | 6.14 |
| SIGA Technologies, Inc. (SIGA)vs › | $234.18M | 21.72 | 10.47 | 8.50 | 9.09 |
| Utah Medical Products, Inc. (UTMD)vs › | $235.43M | 48.62 | 31.63 | 25.23 | 22.81 |
| Profound Medical Corp. (PROF)vs › | $219.48M | 6.45 | 11.52 | 11.11 | 13.89 |
| Invivyd, Inc. (IVVD)vs › | $237.22M | 5.87 | 4.43 | 7.10 | 7.89 |
Current Ratio
10.14
Quick Ratio
10.14
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 10.14 |
| 2026-03-31 | 11.85 |
| 2025-12-31 | 13.33 |
| 2025-09-30 | 14.95 |
| 2025-06-30 | 18.52 |
| 2025-03-31 | 17.36 |
| 2024-12-31 | 17.40 |
| 2024-09-30 | 16.65 |
| 2024-06-30 | 19.69 |
| 2024-03-31 | 20.09 |
| 2023-12-31 | 19.39 |
| 2023-09-30 | 21.00 |
| 2023-06-30 | 21.13 |
| 2023-03-31 | 21.50 |
| 2022-12-31 | 27.57 |
| 2022-09-30 | 40.60 |
| 2022-06-30 | 49.75 |
| 2022-03-31 | 51.06 |
| 2021-12-31 | 60.09 |
| 2021-09-30 | 83.68 |
| 2021-06-30 | 115.95 |
| 2021-03-31 | 15.35 |
| 2020-12-31 | 25.73 |
| 2020-09-30 | 11.15 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 34.62 |
| 2019-09-30 | 7.64 |
| 2019-06-30 | 25.45 |
| 2019-03-31 | 23.14 |
| 2018-12-31 | 266.45 |
